FDA Approves First Drug To Treat Postpartum Depression
Postpartum depression affects nearly one in nine mothers after childbirth. Zulresso would be the first drug dedicated to treating the mental illness.
For the first time in history, the U.S. Food and Drug Administration has approved a new treatment for postpartum depression, a mental illness that affects about one in after childbirth, according to the Centers for Disease Control and Prevention.
